Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 2, 2006, Pages 434-440

  Dahl, Ronald ^a   Kapp, Alexander ^b   Colombo, Giselda ^c   de Monchy, Jan G R ^d   Rak, Sabina ^e   Emminger, Waltraud ^f   Rivas, Montserrat Fernández ^g   Ribel, Mette ^h   Durham, Stephen R ⁱ  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f Allergie Ambulatorium Rennweg Vienna   (Austria)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^h ALK ABELLÓ   (Denmark)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergy; asthma; double blind; grass pollen; immunotherapy; Phleum pratense; placebo controlled; rhinoconjunctivitis; sublingual; tablet based

Indexed keywords

ALLERGEN; BUDESONIDE; DESLORATADINE; GRAZAX; IMMUNOGLOBULIN E; PLACEBO; PREDNISONE;

ADULT; APPLICATION SITE PRURITUS; APPLICATION SITE SWELLING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EAR PRURITUS; FEMALE; GRASS POLLEN; HUMAN; INFLUENZA; LIP ANGIOEDEMA; MAJOR CLINICAL STUDY; MALE; MOUTH EDEMA; MULTICENTER STUDY; PHARYNX EDEMA; PHARYNX HYPEREMIA; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; RHINOPHARYNGITIS; SEASON; SIDE EFFECT; THROAT IRRITATION; THROAT SWELLING; TONGUE EDEMA; TREATMENT WITHDRAWAL; VOICE CHANGE;

ADMINISTRATION, SUBLINGUAL; ADULT; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PHLEUM; RHINITIS, ALLERGIC, SEASONAL; TABLETS;

EID: 33746691245     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.05.003     Document Type: Article

References (22)

1. Dahl R., Andersen P.S., Chivato T., Valovirta E., and de Monchy J. National prevalence of respiratory allergic disorders. Respir Med 98 (2004) 398-403
2. White P., Smith H., Baker N., Davis W., and Frew A. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?. Clin Exp Allergy 28 (1998) 266-270
3. Walker S.M., Pajno G.B., Lima M.T., Wilson D.R., and Durham S.R. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 107 (2001) 87-93
4. Varney V.A., Gaga M., Frew A.J., Aber V.R., Kay A.B., and Durham S.R. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 302 (1991) 265-269
5. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien F., Noble W., et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341 (1999) 468-475
6. Johnstone D.E., and Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics 42 (1968) 793-802
7. Moller C., Dreborg S., Ferdousi H.A., Halken S., Host A., Jacobsen L., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109 (2002) 251-256
8. Passalacqua G., Baena-Cagnani C.E., Berardi M., and Canonica G.W. Oral and sublingual immunotherapy in paediatric patients. Curr Opin Allergy Clin Immunol 3 (2003) 139-145
9. Roches A.D., Paradis L., Menardo J.L., Bouges S., Daures J.P., and Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99 (1997) 450-453
10. Passalacqua G., Lombardi C., and Canonica G.W. Sublingual immunotherapy: an update. Curr Opin Allergy Clin Immunol 4 (2004) 31-36
11. Wilson D.R., Torres L.M., and Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005) 4-12
12. Malling H.J. Is sublingual immunotherapy clinically effective?. Curr Opin Allergy Clin Immunol 2 (2002) 523-531
13. Kleine-Tebbe J., Ribel M., and Herold D.A. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 61 (2006) 181-184
14. Durham S.R., Yang W.H., Pedersen M.R., Johansen N., and Rak S. Sublingual once-daily grass-pollen immunotherapy: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809
15. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects (1996), World Medical Association, Republic of South Africa
16. Frew A., Powell R.J., Corrigan C.J., and Durham S. Efficacy and safety of specific immunotherapy with SQ-allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 319-325
17. Wilson A.M., O'Byrne P.M., and Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 116 (2004) 338-344
18. Dahl R., Stender A., and Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 61 (2006) 185-190
19. Till S.J., Francis J.N., Nouri-Aria K., and Durham S.R. Mechanisms of immunotherapy. J Allergy Clin Immunol 113 (2004) 1025-1034
20. Robinson D.S., Larche M., and Durham S.R. Tregs and allergic disease. J Clin Invest 114 (2004) 1389-1397
21. Walker S.M., Varney V.A., Gaga M., Jacobson M.R., and Durham S.R. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 50 (1995) 405-413
22. Lima M.T., Wilson D., Pitkin L., Roberts A., Nouri-Aria K.T., Jacobson M., et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 32 (2002) 507-514